ABMT (Advanced BioMedical Technologies) Cyclically Adjusted FCF per Share: $0.00 (As of Jul. 2021)


What is Advanced BioMedical Technologies Cyclically Adjusted FCF per Share?

Advanced BioMedical Technologies ABMT Cyclically Adjusted FCF per Share is $0.00 as of Jul. 2021.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Advanced BioMedical Technologies's adjusted free cash flow per share for the three months ended in Jul. 2021 was $-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Jul. 2021.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-08), Advanced BioMedical Technologies's current stock price is $0.0005. Advanced BioMedical Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Jul. 2021 was $0.00. Advanced BioMedical Technologies's Cyclically Adjusted Price-to-FCF of today is .


Advanced BioMedical Technologies  (OTCPK:ABMT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Advanced BioMedical Technologies Cyclically Adjusted FCF per Share Related Terms


Advanced BioMedical Technologies Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Cyclically Adjusted FCF per Share Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ABMT vs VYCO, ADMT, THMO: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced BioMedical Technologies Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Cyclically Adjusted Price-to-FCF falls into.



Advanced BioMedical Technologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Advanced BioMedical Technologies's adjusted Free Cash Flow per Share data for the three months ended in Jul. 2021 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jul. 2021 (Change)*Current CPI (Jul. 2021)
=-0.001/273.0030*273.0030
=-0.001

Current CPI (Jul. 2021) = 273.0030.

Advanced BioMedical Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201110 -0.002 226.421 -0.002
201201 -0.003 226.665 -0.004
201204 -0.002 230.085 -0.002
201207 -0.003 229.104 -0.004
201210 -0.003 231.317 -0.004
201301 -0.003 230.280 -0.004
201304 -0.003 232.531 -0.004
201307 -0.002 233.596 -0.002
201310 -0.003 233.546 -0.004
201401 -0.003 233.916 -0.004
201404 -0.003 237.072 -0.003
201407 -0.003 238.250 -0.003
201410 -0.003 237.433 -0.003
201501 -0.004 233.707 -0.005
201504 -0.004 236.599 -0.005
201507 -0.003 238.654 -0.003
201510 -0.003 237.838 -0.003
201601 -0.003 236.916 -0.003
201604 0.001 239.261 0.001
201607 -0.002 240.628 -0.002
201610 -0.002 241.729 -0.002
201701 -0.002 242.839 -0.002
201704 -0.001 244.524 -0.001
201707 -0.002 244.786 -0.002
201710 -0.003 246.663 -0.003
201801 -0.003 247.867 -0.003
201804 -0.003 250.546 -0.003
201807 -0.003 252.006 -0.003
201810 -0.004 252.885 -0.004
201901 -0.003 251.712 -0.003
201904 -0.003 255.548 -0.003
201907 -0.002 256.571 -0.002
201910 -0.003 257.346 -0.003
202001 -0.001 257.971 -0.001
202004 -0.003 256.389 -0.003
202007 0.001 259.101 0.001
202010 0.011 260.388 0.012
202101 -0.008 261.582 -0.008
202104 -0.003 267.054 -0.003
202107 -0.001 273.003 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
Advanced BioMedical Technologies (ABMT) has a Cyclically Adjusted FCF per Share of $0.00 as of Jul. 2021. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Cyclically Adjusted FCF per Share too high?
Advanced BioMedical Technologies' current Cyclically Adjusted FCF per Share is $0.00.
How does Advanced BioMedical Technologies' Cyclically Adjusted FCF per Share compare to VYCO and ADMT?
Advanced BioMedical Technologies' Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Cyclically Adjusted FCF per Share of $0.00. The current Cyclically Adjusted FCF per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Cyclically Adjusted FCF per Share is $0.00 as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.